LAMP2 and age-related macular degeneration: Previous research had shown decreased levels of LAMP-2 in the RPE of AMD patients (Notomi et al, 2019), which we now have shown to be, at least partially, due to a decrease in the alternative splicing product and limiting CMA effector LAMP-2A.